Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report.
about
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysisPoint-of-care diagnosis of tuberculosis: past, present and futureA simple method to quantitate IP-10 in dried blood and plasma spotsMultiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigensProduction of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states.The immunology of tuberculosis: from bench to bedside.Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia.Identification of tuberculosis-associated proteins in whole blood supernatantHost cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB.Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis.Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaImmune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis.Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.Discriminating between latent and active tuberculosis with multiple biomarker responses.Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.Lateral flow assay for simultaneous detection of cellular- and humoral immune responses.Clinical immunology and multiplex biomarkers of human tuberculosisEvaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts.Immunodiagnosis of tuberculosis: a dynamic view of biomarker discoveryAssociation between serum soluble CD40 ligand levels and mortality in patients with severe sepsis.Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndromePost-treatment change in Mycobacterium tuberculosis antigen-stimulated tumor necrosis factor-alpha release in patients with active tuberculosisGene expression profiling identifies candidate biomarkers for active and latent tuberculosisNew biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent InfectionCytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis.Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.Immunological biomarkers of tuberculosis.Tuberculosis assays: past, present and future.Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies.The pathology of Mycobacterium tuberculosis infection.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Challenges in immunodiagnostic tests for leprosy.
P2860
Q22242874-E8921741-1FCB-43B9-A914-3735033A790EQ27004667-D0AB8D01-D13D-4156-A31E-6206F59D1D79Q28727912-46EE2DE4-7D05-4C3F-B675-8FDF58A7B538Q28742421-BD5E485E-8A5B-45EC-AE72-C8C82F6F7D03Q33682037-0FCB07A5-6A15-4838-97B6-B5A3854D97C7Q33696695-AD3F105C-F82A-4F1E-9D62-461FDB3837DCQ33777367-EF3C4141-3EE9-496E-BC10-FF36F459128EQ33825672-61714674-7659-46C4-87DB-292707896ABEQ33850429-1741A09C-EE45-4B90-B4B9-85C5428E3A3CQ33905078-1DE1A192-E09F-4605-9BF1-4EC35ED83E56Q33914010-4F9658C2-54E9-410B-97D8-578D4854FF69Q34014562-841BF45C-562C-4F90-B33E-088B5ABE76B9Q34097641-1B2403E3-FE5A-4C21-B2A3-E30DEE5B0EA0Q34133162-8DFBC6CB-B95A-44F6-9A8E-7F2962A7825EQ34168041-DF9D881F-F16A-45B2-B9F2-A71292881904Q34302593-A6CC860B-ADC1-408E-A5D1-25F046A356C3Q34378280-8A04617C-AB3F-4109-AA8B-AA8E298AB6D8Q34731357-310D31CA-6084-4057-95D5-D3CDF3D13E86Q34958633-CB36EF81-9DF3-422A-B752-4BCD50ADE21FQ35048697-A956F8D8-7EC4-4206-AB2C-148B4722E2FEQ35226256-04F4E5C8-6EF5-48E2-BF98-02366B9E75EBQ35245278-CA9F8A97-E9AD-4C1F-A112-CD68DCFDD555Q35331571-DBD46EBD-CD69-474D-81B9-520F696F403DQ35361654-3A751B8B-AA92-4E3D-BE94-D36D8EDF24FBQ35559467-559247CD-25BB-46BD-8AEE-F45F300A2BCDQ35622163-5DD2CD9F-F1EA-41D9-B20D-4A49FC6BBD52Q35681015-084BE19B-DE65-42F4-B869-C867D008092EQ35906290-184F3C12-F42D-427F-9025-228AA0F703EDQ35936136-59242410-869A-4B3E-9447-F447B8FAEB66Q35976624-E7161C60-ADF7-43DD-828D-7B1FDBF15347Q36148431-AAB38EFD-FE1D-4757-B485-72E3E0F64BD7Q36599355-EE151083-C03B-465B-B2C8-B8F834E63000Q37353352-47795998-AF45-4EC1-A6D7-617F662294FEQ37611851-C3A7CFA1-548E-42CB-9A85-1456EB92213CQ37862987-293ACBA9-79EF-49A9-8E06-F350D179CBBEQ37866817-3C1DBA78-F40E-46A5-98D3-DFF1145364BBQ37953955-4B6349A4-DC57-4DB6-A01C-B8E1E052BBB4Q37977379-BEB1E621-6565-46E4-ABD1-E35C2A5BE809Q37988577-6FDCD73E-CC2E-4CEA-A825-BF8F50F69659Q38093850-8F0E27E6-DB21-4548-B7C9-2DEFA3588237
P2860
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host markers in QuantiFERON su ...... infection: preliminary report.
@en
Host markers in QuantiFERON su ...... infection: preliminary report.
@nl
type
label
Host markers in QuantiFERON su ...... infection: preliminary report.
@en
Host markers in QuantiFERON su ...... infection: preliminary report.
@nl
prefLabel
Host markers in QuantiFERON su ...... infection: preliminary report.
@en
Host markers in QuantiFERON su ...... infection: preliminary report.
@nl
P2860
P50
P356
P1476
Host markers in QuantiFERON su ...... infection: preliminary report.
@en
P2093
Gillian F Black
Paul D van Helden
P2860
P2888
P356
10.1186/1471-2466-9-21
P577
2009-05-16T00:00:00Z
P5875
P6179
1011189068